| Feig, Francois (Merck Serono 200706 Head Global Therapeutic Area Endocrinology + Cardio-Metabolic Care) |
endocrine/metabolic disease |
Merck (DE) (Group) |
Germany |
| Feige, Michael (Methrom 201301– Managing Director of Deutsche Methrom Prozessanalytik GmbH & Co KG) |
Managing Director |
Metrohm (Group) |
Germany |
| Feingold, Jay (ADC Therapeutics 201902 CMO + SVP Clinical Development) |
Chief Medical Officer (CMO) |
ADC Therapeutics (Group) |
Switzerland |
| Feist, Frank (BlueCatBio 201411– CEO + Founder before NobleGen Biosciences + BC + Olympus America + Polytechnos) |
Chief Executive Officer (CEO) |
BlueCatBio (BCB) (Group) |
United States (USA) |
| Felber, Erich (Biovertis 200409– CEO before Micromet) |
Chief Executive Officer (CEO) |
Deinove (Group) |
Austria |
| Felciano, Ramon (Ingenuity Systems 200705 Chief Technology Officer) |
n. a. |
Qiagen (Group) |
United States (USA) |
| Feldsine, Phil (BioControl Systems 201701 CEO) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
United States (USA) |
| Felgenhauer, Thomas (Pepperprint GmbH 2011– Head RnD before DKFZ) |
Research & Development Manager |
Pepperprint GmbH |
Germany |
| Feling, Nicole (Köhl et Feling 201310 Partner + Bicoll PR) |
Public Relations Manager / Investor Relations Manager |
Innovation Industries (NL) |
Germany |
| Fellenberg, Friederike (NCT Heidelberg 201810 Press + Public Relations) |
Public Relations Manager / Investor Relations Manager |
National Center for Tumor Diseases (NCT) Heidelberg (Nationales Centrum für Tumorerkrankungen) |
Germany |
| Feller, Christine |
n. a. |
Baden-Württembergische Bank AG |
|
| Fellner, Peter (Acambis 200703 President) |
Board member, non-executive |
Sanofi (Group) [since May 2011] |
United Kingdom (GB) |
| Felzmann, Thomas (AOP Orphan 201110 Managing Director + Founder of Activartis Biotech GmbH) |
Managing Director |
Élan (Group) |
Austria |
| Fenge, Christel (Sartorius 201201 VP Fermentation Technologies at Sartorius Stedim Biotech) |
President/Director/Head Business Group/Unit/Division |
Sartorius (Group) |
Germany |
| Fenzl, Edgar J. (FGK Clinical Research 201411 Managing Director + Co-founder) |
Managing Director |
FGK Clinical Research GmbH |
Germany |
| Fernández, Javier (Vitro SA 201805 CEO) |
Chief Executive Officer (CEO) |
Vitro (ES) (Group) |
Spain (España) |
| Fernández-Alba, Amadeo Rodriguez (Univ Almería 201311 Prof + EURL-FV) |
Professor |
University of Almería (Universidad de Almería) |
Spain (España) |
| Ferneding, Stephan (Accurion GmbH 201602 Managing Director) |
Managing Director |
Accurion (Group) |
Germany |
| Ferreira, Isabel (Versameb 201910c– CBO before Roche Partnering + Prosensa) |
Chief Business Officer (CBO) |
Versameb AG |
Switzerland |
| Fert, Vincent (HalioDx 201503– CEO + CO-founder before Ipsogen 200708– President + CEO) |
Chief Executive Officer (CEO) |
HalioDx S.A.S. |
France |
| Fertig, Niels (Nanion Technologies GmbH 201102 Managing Director CEO) |
Managing Director |
Nanion (Group) |
Germany |
| Fesik, Stephen W. (Vanderbilt Univ 200905– Professor before Abbott divisonal VP Cancer Research) |
Professor |
Abbott (Group) |
United States (USA) |
| Fesseler, Jana (BioRegio STERN 201802–) |
Cluster Manager |
BioRegio STERN Management GmbH |
Germany |
| Fest, Constantin (Merck (DE) 201301– Head Investor Relations joined 6/12 before Lanxess) |
Public Relations Manager / Investor Relations Manager |
Merck (DE) (Group) |
Germany |
| Festel, Gunter (Festel Capital 200501) |
n. a. |
Festel Capital |
Switzerland |
| Feuerstein, Marco (microDimensions GmbH 2011– Managing Director (COO) + Co-founder) |
Managing Director |
microDimensions GmbH |
Germany |
| Feuillet, Catherine (Bayer 201401 Head of Trait Research at Bayer CropScience) |
Researcher (industry) |
Bayer (Group) |
Germany |
| Feurstein, Burkhard (Oridis Biomarkers 201205– CEO + Partner at GCP gamma capital partners) |
Chief Executive Officer (CEO) |
Oridis Biomarkers GmbH |
Austria |
| Fewster, Martin (World Trade Group 201203 Marketing Manager at WTG Events) |
Sales Manager / Marketing Manager |
World Trade Group Ltd. (WTG) |
United Kingdom (GB) |
| Fibig, Andreas (IFF 201409– CEO before Bayer HealthCare Pharma + Pfizer + P&U + Boehringer Ingelheim) |
Chief Executive Officer (CEO) |
International Flavors & Fragrances Inc. (IFF) |
United States (USA) |
| Fichtner, Caroline (High-Tech Gründerfonds 201002 Senior Investment Manager) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Fido, Markus (Vela Laboratories 201107 CEO) |
Chief Executive Officer (CEO) |
Vela pharmazeutische Entwicklung und Laboranalytik GmbH (Vela Laboratories) |
Austria |
| Fiebich, Bernd L. (VivaCell 201104 Managing Director) |
Managing Director |
VivaCell Biotechnology GmbH |
Germany |
| Fiebig, Heinz-Herbert (Oncotest GmbH 201108 Managing Director) |
Managing Director |
Charles River (Group) |
Germany |
| Fiedler, Ulrike (Coral BioNet 2000– Managing Director of Scil Proteins) |
Managing Director |
UV-Cap (Group) |
Germany |
| Fiehn, Hendrik (GeSiM 200809) |
Sales Manager / Marketing Manager |
GeSiM – Gesellschaft für Silizium-Mikrosysteme mbH |
Germany |
| Field, Richard (CCS Cell Culture Service 201006 COO North America) |
Regional manager |
Evotec (Group) |
United States (USA) |
| Fields, Anne Marie (Rx Communications Group 202104 Managing Director) |
Public Relations Manager / Investor Relations Manager |
Rx Communications Group LLC (RxIR) |
United States (USA) |
| Fietz, Carsten (c-LEcta GmbH 201509– Head Finance + Administration before CFO) |
Financial Manager (CFO, Financial Director, etc.) |
c-LEcta GmbH |
Germany |
| Figulla, Laura (Coramaze Technologies 201401– Managing Director + Co-founder) |
Managing Director |
Coramaze Technologies GmbH |
Germany |
| Filerman, Marc (Germany (govt) 201906– CEO of German Accelerator Life Sciences before Secora + MGH) |
Cluster Manager |
Germany (govt) |
United States (USA) |
| Filliol, Olivier (Mettler Toledo 199801– CEO) |
Chief Executive Officer (CEO) |
Mettler-Toledo (Group) |
Switzerland |
| Finan, Peter (Epidarex Capital 2014– Venture Partner + Karus Therapeutics 201410– Head of Biology before Novartis) |
Venture Partner |
Karus Therapeutics Ltd. |
United Kingdom (GB) |
| Finbow, Anthony (Eagle Genomics 201501– CEO before Executive Chairman) |
Chief Executive Officer (CEO) |
Eagle Genomics Ltd. |
United Kingdom (GB) |
| Fink, Klaus (Eppendorf 2006 CEO joined 1989) |
Chief Executive Officer (CEO) |
Eppendorf (Group) |
Germany |
| Fink, Thomas (Portus Corporate Finance 200804 Managing Director + CCM 200804 Managing Director) |
Managing Director |
CCM Columbus Capital Management GmbH |
Germany |
| Finkbeiner, Petra (PANATecs 201003) |
Sales Manager / Marketing Manager |
Zukunftsfonds Heilbronn (Group) |
Germany |
| Finke, Gandolf (Fosanis GmbH 201908 Managing Director + Co-Founder) |
Managing Director |
Fosanis GmbH |
Germany |
| Firouz, Fereydoun (EMD Serono 200804 CEO) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
United States (USA) |
| Fisch, Igor (Selexis 201008 CEO + co-founder) |
Chief Executive Officer (CEO) |
JSR Corporation (Group) |
Switzerland |
| Fischer, Achim (200407– Gentana) |
n. a. |
Gentana GmbH |
Germany |
| Fischer, Benjamin (Hamburg (govt) 201707 Program Adivsor Innovation at IFB Hamburg) |
n. a. |
Hamburg (govt region) |
Germany |
| Fischer, Bernd (Univ Lübeck 1996– Professor Mathematics + Fraunhofer MEVIS Lübeck 201004– Head) |
Professor |
University of Lübeck (Universität zu Lübeck, UzL) |
Germany |
| Fischer, Bernhard (Apeptico 200903 CEO) |
Chief Executive Officer (CEO) |
Apeptico Forschung und Entwicklung GmbH |
Austria |
| Fischer, Florian (MedVenture Partners 201305 Managing Director + Affimed CFO 201510) |
Managing Director |
MedVenture Partners GmbH |
Germany |
| Fischer, Gunter S. (Max Planck 199606–200907– founding Director Research Unit for Enzymology Protein Folding Halle) |
Professor |
Max Planck Society for the Advancement of Science |
Germany |
| Fischer, Hartmut (A&M Labor 201201 Managing Director) |
Managing Director |
A&M Labor für Analytik und Metabolismusforschung Service Gmb |
|
| Fischer, Heinrich (Tecan 200702– Board Member before Saurer) |
Board member |
Tecan (Group) |
Switzerland |
| Fischer, Karsten (Memo Therapeutics 201806– CEO before BioMedPartners + WestLB) |
Chief Executive Officer (CEO) |
Memo Therapeutics AG |
Switzerland |
| Fischer, Markus (PolyQuant 201306 Managing Director + Entelechon GmbH 200709 Managing Director) |
Managing Director |
PolyQuant GmbH |
Germany |
| Fischer, Michael (Univ Kiel 200505) |
n. a. |
University of Kiel (Christian-Albrechts-Universität, CAU) |
Germany |
| Fischer, Rainer (IUCT 1998) |
n. a. |
Fraunhofer (Group) |
Germany |
| Fischer, Renate (Seramun Diagnostica GmbH 202006 Managing Director) |
Managing Director |
Seramun Diagnostica GmbH |
Germany |
| Fischer, Robert (Omeicos Therapeutics GmbH 201312 Managing Director (CSO)) |
Managing Director |
Omeicos (Group) |
Germany |
| Fischer, Stefan (Algiax 201104– CFO before NewLab BioQuality 200201– CFO) |
Chief Financial Officer (CFO) |
Algiax Pharmaceuticals GmbH |
Germany |
| Fischer, Stefan (TVM 202010– promoted to Managing Partner (Finance) before General Partner + CFO) |
General Partner (venture partner) |
TVM (Group) |
Germany |
| Fischer, Stefan (Univ Lübeck 202006 Professor at Institute for Telematics + Vice President of Transfer + Digitalisation) |
Professor |
University of Lübeck (Universität zu Lübeck, UzL) |
Germany |
| Fischer, Stephan (MAB Discovery GmbH 201209 Managing Director + Founder) |
Managing Director |
MAB Discovery GmbH |
Germany |
| Fischer, Thomas (Eucodis 200912– CEO) |
Chief Executive Officer (CEO) |
Eucodis Bioscience (Group) |
Austria |
| Fischer, Wolfgang (Affimed 201709– COO before Sandoz Biopharmaceuticals + Novartis) |
Chief Operating Officer (COO) |
Affimed (Group) |
Germany |
| Fischer, Wolfgang H. (Salk Institute 201107 Staff Scientist + Head Mass Spec Core Facilty) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
Salk Institute for Biological Studies, The |
United States (USA) |
| Fischer-Colbrie, Mark (Labcyte 201109 CEO) |
Chief Executive Officer (CEO) |
Danaher (Group) |
United States (USA) |
| Fischer-Knuppertz, Wulf (CellTool 202001– CEO before Biocrates 201306–201909 + Fisher Scientific + Roche Diagnostics) |
Chief Executive Officer (CEO) |
CellTool GmbH |
Germany |
| Fischli, Walter (Altos Venture 201808 Chair + co-founder of Actelion) |
Investment Manager |
Altos Venture (CH) |
Switzerland |
| Fisher, Valeria (Trophic Communications 201906) |
Public Relations Manager / Investor Relations Manager |
Trophic Communications GmbH |
Germany |
| Fisher-Pollard, Miles (Genedata 202002 Public Relations) |
Public Relations Manager / Investor Relations Manager |
Genedata (Group) |
Switzerland |
| Fisherman, Jason (C4 Therapeutics 201601– CEO before Synthesis Capital + Advent International) |
Chief Executive Officer (CEO) |
C4 Therapeutics Inc. (C4T) |
United States (USA) |
| Fishman, Mark (Novartis Institutes of BioMedical Research 200509 President) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
Switzerland |
| Fitzgerald, Daniel (Geneva Biotech 201711 CEO) |
Chief Executive Officer (CEO) |
Geneva Biotech (CH) |
Switzerland |
| FitzGerald, Kevin (Activiomics 201304– CEO F-Star 201104–201205 CEO LEFT 5/12 + Isogenica + CAT) |
Chief Executive Officer (CEO) |
F-Star (Group) |
Austria |
| FitzGerald, Peter (Randox Laboratories 200710 Managing Director) |
Managing Director |
Randox (Group) |
United Kingdom (GB) |
| Fitzpatrick, David (Max Planck 201212– Scientific Director + CEO of MPFI) |
President/Director/Head Business Group/Unit/Division |
Max Planck Society for the Advancement of Science |
United States (USA) |
| Flach, Jürgen (Sirion Biotech 201106 Managing Director CEO) |
Chief Executive Officer (CEO) |
Sirion Biotech (Group) |
Germany |
| Flad, Thomas (PANATecs 201104 Head Technical Sales before 200512 Managing Director) |
Sales Manager / Marketing Manager |
Zukunftsfonds Heilbronn (Group) |
Germany |
| Flade, Isabell (CeMeT GmbH 201407– Managing Director) |
Managing Director |
CeMeT GmbH – Center for Metagenomics |
Germany |
| Fladrich, Mark (Grünenthal 201709– CCO before AstraZeneca) |
Chief Commercial Officer (CCO) |
Grünenthal (Group) |
Germany |
| Flamm, Robert (Burns McClellan 202103 before Ruth Group 201612) |
Public Relations Manager / Investor Relations Manager |
Burns McClellan Inc. |
United States (USA) |
| Flatman, Steve (Lonza 201101 Head Mammalian Development Services) |
Research & Development Manager |
Lonza (Group) |
Switzerland |
| Fleck, Roman (Index Ventures 2006– Principal at Geneva office before Boehringer Ingelheim) |
Principal (venture capital) |
Index Ventures |
Switzerland |
| Fleck, Stephan (Whatman 200711– before Bayer) |
n. a. |
General Electric (Group) |
United Kingdom (GB) |
| Fleckenstein, Tamara (Elementar 201701 Event + External Communications Manager) |
Public Relations Manager / Investor Relations Manager |
Elementar (Group) |
Germany |
| Fleig, Thomas (Valerius Bioharma 201805 CFO before Ernst & Young) |
Chief Financial Officer (CFO) |
Valerius Biopharma AG |
Switzerland |
| Fleming, Bill (Oxitec 201704 CFO joined 2010 before Bayer + OBN 201704– Board Member) |
Chief Financial Officer (CFO) |
Third Security (Randal J. Kirk) (Group) |
United Kingdom (GB) |
| Flenker, Ulrich (German Sport University 200804) |
n. a. |
Deutsche Sporthochschule Köln |
Germany |
| Flensberg, Mikael (CLC bio 201304 Director Global Partner Relations) |
Business Development Manager / Strategy Manager |
Qiagen (Group) |
Denmark |
| Fleurant, Mylène (Novimmune 201609– Global Head of Quality before Alvotech + Novartis Pharma + Merck Serono) |
Chief Financial Officer (CFO) |
Novimmune S.A. |
Switzerland |
| Fließbach, Holger (Alopex 200507– Managing Director) |
Managing Director |
Alopex GmbH |
Germany |
| Flintholm Jørgensen, Keld (Lundbeck 201904– EVP + CBO before Roche Global Head of Strategic Partnering) |
Chief Business Officer (CBO) |
Lundbeck (Group) |
Denmark |
| Flon, Aude (Sud de France 201111 Project Manager Multi-industrial Sector) |
Administrative Officer (personnel) |
Sud de France Développement |
France |
| Flores, Lalo (Century Therapeutics 201907 CEO) |
Chief Executive Officer (CEO) |
Century Therapeutics (US) |
United States (USA) |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 17 18 19 ... 73 74 75 
![Picture [iito] Made Without Love 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-made-without-love.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
